ACURA PHARMACEUTICALS Trademark Information

Trademark by Acura Pharmaceuticals, Inc.

Pharmaceutical preparations to be used in opioid-containing pharmaceuticals to minimize the possibility of abuse and addiction to the opioid-containing pharmaceuticals

Pharmaceutical research and development services

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: 3/29/2004
First Use In Commerce: 3/29/2004
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: 3/29/2004
First Use In Commerce: 3/29/2004
General Information
Word mark: ACURA PHARMACEUTICALS
Status/Status Date:
REGISTERED AND RENEWED
9/28/2016
Serial Number: 78375565
Filing Date: 2/27/2004
Registration Number: 3114970
Registration Date: 7/11/2006
Goods and Services: Pharmaceutical preparations to be used in opioid-containing pharmaceuticals to minimize the possibility of abuse and addiction to the opioid-containing pharmaceuticals
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 2/15/2005
Last Applicant/Owner:
Acura Pharmaceuticals, Inc.
PALATINE, IL 60067
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: ("PHARMACEUTICALS")
Correspondent:
MORGAN, LEWIS & BOCKIUS LLP
Attention: TMSU
1111 PENNSYLVANIA AVENUE, NW
WASHINGTON DC 20004
Current Status:
REGISTERED AND RENEWED
9/28/2016
Correspondent Search:
Carole R. Klein is a correspondent of ACURA PHARMACEUTICALS trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on